Showing results (11-20 of 69) with videos related to

Sort By:
Pageof 7
Frontiers in Pediatrics|August 8, 2022
The safety of blinatumomab in pediatric patients with acute lymphoblastic leukemia: A systematic review and meta-analysisMaria Maddalena Marrapodi, Annamaria Mascolo, Gabriella di Mauro, et al.
Therapeutic Advances in Drug Safety|April 28, 2025
Pharmacovigilance study on the reporting frequency of atrial fibrillation with immune checkpoint inhibitors: insights from FDA Adverse Event Reporting SystemNunzia Balzano, Annamaria Mascolo, Donatella Ruggiero, et al.
Inflammopharmacology|June 28, 2018
Neuropsychiatric clinical manifestations in elderly patients treated with hydroxychloroquine: a review articleAnnamaria Mascolo, Pasquale Maria Berrino, Pietro Gareri, et al.
Frontiers in Pharmacology|June 28, 2018
Pillars and Pitfalls of the New Pharmacovigilance Legislation: Consequences for the Identification of Adverse Drug Reactions Deriving From Abuse, Misuse, Overdose, Occupational Exposure, and Medication ErrorsMaurizio Sessa, Gabriella di Mauro, Annamaria Mascolo, et al.
Pharmacological Reports : PR|July 10, 2026
The onset of posterior reversible encephalopathy syndrome (PRES) and reversible cerebral vasoconstriction syndrome (RCVS) with the use of decongestant agents: a European pharmacovigilance analysisAntonietta Anatriello, Andrea Cantone, Ciro Pentella, et al.
Expert Opinion on Drug Safety|December 19, 2024
T-cell malignancies following CAR T-Cell therapy: insights from the FDA Adverse Event Reporting System (FAERS)Raffaella Di Napoli, Nunzia Balzano, Rosanna Ruggiero, et al.
Journal of Personalized Medicine|September 28, 2024
Risk of Rhabdomyolysis Associated with Dexmedetomidine Use over the Past 10 Years: Insights from the EudraVigilance DatabaseNunzia Balzano, Annamaria Mascolo, Raffaella Di Napoli, et al.
Frontiers in Pediatrics|May 11, 2023
The efficacy and the safety of eltrombopag in pediatric patients with severe aplastic anemia: a systematic reviewMaria Maddalena Marrapodi, Annamaria Mascolo, Domenico Roberti, et al.
Plos One|July 29, 2016
Effect of Chronic Kidney Diseases on Mortality among Digoxin Users Treated for Non-Valvular Atrial Fibrillation: A Nationwide Register-Based Retrospective Cohort StudyMaurizio Sessa, Annamaria Mascolo, Mikkel Porsborg Andersen, et al.
Frontiers in Pharmacology|May 23, 2019
Preventable Cases of Oral Anticoagulant-Induced Bleeding: Data From the Spontaneous Reporting SystemAnnamaria Mascolo, Rosanna Ruggiero, Maurizio Sessa, et al.
Pageof 7